{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:08:43Z","timestamp":1792372123144,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12185-016-1951-0","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T10:16:46Z","timestamp":1455272206000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes"],"prefix":"10.1007","volume":"103","author":[{"given":"Jean-Hugues","family":"Dalle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis Peffault","family":"de Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"1951_CR1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103270","volume":"52","author":"I Ghemlas","year":"2015","unstructured":"Ghemlas I, Li H, Zlateska B, Klaassen R, Fernandez CV, Yanofsky RA, Wu J, Pastore Y, Silva M, Lipton JH, et al. Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes. J Med Genet. 2015;52:575\u201384.","journal-title":"J Med Genet"},{"key":"1951_CR2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3324\/haematol.2014.113456","volume":"100","author":"MY Zhang","year":"2015","unstructured":"Zhang MY, Keel SB, Walsh T, Lee MK, Gulsuner S, Watts AC, Pritchard CC, Salipante SJ, Jeng MR, Hofmann I, et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica. 2015;100:42\u20138.","journal-title":"Haematologica"},{"key":"1951_CR3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.beha.2014.10.002","volume":"27","author":"BP Alter","year":"2014","unstructured":"Alter BP. Fanconi anemia and the development of leukemia. Best Pract Res Clin Haematol. 2014;27:214\u201321.","journal-title":"Best Pract Res Clin Haematol"},{"key":"1951_CR4","doi-asserted-by":"crossref","first-page":"132856","DOI":"10.1155\/2012\/132856","volume":"2012","author":"N Ameziane","year":"2012","unstructured":"Ameziane N, Sie D, Dentro S, Ariyurek Y, Kerkhoven L, Joenje H, Dorsman JC, Ylstra B, Gille JJ, Sistermans EA, de Winter JP. Diagnosis of Fanconi anemia: mutation analysis by next-generation sequencing. Anemia. 2012;2012:132856.","journal-title":"Anemia"},{"key":"1951_CR5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gde.2015.07.002","volume":"33","author":"M Bogliolo","year":"2015","unstructured":"Bogliolo M, Surralles J. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Curr Opin Genet Dev. 2015;33:32\u201340.","journal-title":"Curr Opin Genet Dev"},{"key":"1951_CR6","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood.V86.7.2856.2856","volume":"86","author":"E Gluckman","year":"1995","unstructured":"Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, Butturini A, Camitta BM, Champlin RE, Friedrich W, et al. Bone marrow transplantation for Fanconi anemia. Blood. 1995;86:2856\u201362.","journal-title":"Blood"},{"key":"1951_CR7","first-page":"422","volume":"95","author":"P Guardiola","year":"2000","unstructured":"Guardiola P, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh JC, Ball SE, Locatelli F, Vermylen C, Skinner R, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood. 2000;95:422\u20139.","journal-title":"Blood"},{"key":"1951_CR8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3324\/haematol.11436","volume":"92","author":"F Locatelli","year":"2007","unstructured":"Locatelli F, Zecca M, Pession A, Morreale G, Longoni D, Di Bartolomeo P, Porta F, Fagioli F, Nobili B, Bernardo ME, et al. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica. 2007;92:1381\u20138.","journal-title":"Haematologica"},{"key":"1951_CR9","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood-2006-07-036657","volume":"109","author":"JE Wagner","year":"2007","unstructured":"Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood. 2007;109:2256\u201362.","journal-title":"Blood"},{"key":"1951_CR10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V87.1.386.386","volume":"87","author":"HJ Deeg","year":"1996","unstructured":"Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386\u201392.","journal-title":"Blood"},{"key":"1951_CR11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/pbc.25303","volume":"62","author":"A Malric","year":"2015","unstructured":"Malric A, Defachelles AS, Leblanc T, Lescoeur B, Lacour B, Peuchmaur M, Maurage CA, Pierron G, Guillemot D, d\u2019Enghien CD, et al. Fanconi anemia and solid malignancies in childhood: a national retrospective study. Pediatr Blood Cancer. 2015;62:463\u201370.","journal-title":"Pediatr Blood Cancer"},{"key":"1951_CR12","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1002\/cncr.23954","volume":"113","author":"C Masserot","year":"2008","unstructured":"Masserot C, Peffault de Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F, Janin A, Soulier J, Gluckman E, Socie G. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer. 2008;113:3315\u201322.","journal-title":"Cancer"},{"key":"1951_CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2141.1983.tb02117.x","volume":"54","author":"E Gluckman","year":"1983","unstructured":"Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol. 1983;54:431\u201340.","journal-title":"Br J Haematol"},{"key":"1951_CR14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.bmt.1701993","volume":"24","author":"C Medeiros","year":"1999","unstructured":"Medeiros C, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant. 1999;24:849\u201352.","journal-title":"Bone Marrow Transplant"},{"key":"1951_CR15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.bmt.1704219","volume":"32","author":"J Fuente de la","year":"2003","unstructured":"de la Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IA, Rahemtulla A, Dokal I. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant. 2003;32:653\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"1951_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood-2003-06-2146","volume":"103","author":"P Guardiola","year":"2004","unstructured":"Guardiola P, Socie G, Li X, Ribaud P, Devergie A, Esperou H, Richard P, Traineau R, Janin A, Gluckman E. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood. 2004;103:73\u20137.","journal-title":"Blood"},{"key":"1951_CR17","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood-2015-02-626002","volume":"125","author":"ML MacMillan","year":"2015","unstructured":"MacMillan ML, DeFor TE, Young JA, Dusenbery KE, Blazar BR, Slungaard A, Zierhut H, Weisdorf DJ, Wagner JE. Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood. 2015;125:3798\u2013804.","journal-title":"Blood"},{"key":"1951_CR18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s12185-012-1079-9","volume":"95","author":"A Shimada","year":"2012","unstructured":"Shimada A, Takahashi Y, Muramatsu H, Hama A, Ismael O, Narita A, Sakaguchi H, Doisaki S, Nishio N, Tanaka M, et al. Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen. Int J Hematol. 2012;95:675\u20139.","journal-title":"Int J Hematol"},{"key":"1951_CR19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2007.06975.x","volume":"140","author":"S Chaudhury","year":"2008","unstructured":"Chaudhury S, Auerbach AD, Kernan NA, Small TN, Prockop SE, Scaradavou A, Heller G, Wolden S, O\u2019Reilly RJ, Boulad F. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol. 2008;140:644\u201355.","journal-title":"Br J Haematol"},{"key":"1951_CR20","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","volume":"122","author":"R Peffault Latour de","year":"2013","unstructured":"de Peffault Latour R, Porcher R, Dalle JH, Aljurf M, Korthof ET, Svahn J, Willemze R, Barrenetxea C, Mialou V, Soulier J, et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122:4279\u201386.","journal-title":"Blood"},{"key":"1951_CR21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbmt.2011.01.001","volume":"17","author":"P Stepensky","year":"2011","unstructured":"Stepensky P, Shapira MY, Balashov D, Trakhtman P, Skorobogatova E, Rheingold L, Brooks R, Revel-Vilk S, Weintraub M, Stein J, et al. Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning. Biol Blood Marrow Transplant. 2011;17:1282\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1951_CR22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.2006.06128.x","volume":"134","author":"H Yabe","year":"2006","unstructured":"Yabe H, Inoue H, Matsumoto M, Hamanoue S, Koike T, Ishiguro H, Koike H, Suzuki K, Kato S, Kojima S, et al. Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia. Br J Haematol. 2006;134:208\u201312.","journal-title":"Br J Haematol"},{"key":"1951_CR23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2010.08078.x","volume":"149","author":"ML MacMillan","year":"2010","unstructured":"MacMillan ML, Wagner JE. Haematopoeitic cell transplantation for Fanconi anaemia\u2014when and how? Br J Haematol. 2010;149:14\u201321.","journal-title":"Br J Haematol"},{"key":"1951_CR24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2011.08598.x","volume":"154","author":"E Gluckman","year":"2011","unstructured":"Gluckman E, Ruggeri A, Volt F, Cunha R, Boudjedir K, Rocha V. Milestones in umbilical cord blood transplantation. Br J Haematol. 2011;154:441\u20137.","journal-title":"Br J Haematol"},{"key":"1951_CR25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","volume":"97","author":"A Bacigalupo","year":"2012","unstructured":"Bacigalupo A, Socie G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M, Risitano AM, Dufour C, Passweg JR, Oneto R, et al. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica. 2012;97:1142\u20138.","journal-title":"Haematologica"},{"key":"1951_CR26","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2011-05-354001","volume":"118","author":"M Eapen","year":"2011","unstructured":"Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JC, Deeg HJ. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood. 2011;118:2618\u201321.","journal-title":"Blood"},{"key":"1951_CR27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","volume":"110","author":"H Schrezenmeier","year":"2007","unstructured":"Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 2007;110:1397\u2013400.","journal-title":"Blood"},{"key":"1951_CR28","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2015-04-639476","volume":"125","author":"E Gluckman","year":"2015","unstructured":"Gluckman E. Improving survival for Fanconi anemia patients. Blood. 2015;125:3676.","journal-title":"Blood"},{"key":"1951_CR29","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.3324\/haematol.2013.098954","volume":"99","author":"A Talbot","year":"2014","unstructured":"Talbot A, Peffault de Latour R, Raffoux E, Buchbinder N, Vigouroux S, Milpied N, Leblanc T, Soulier J, Michallet M, Socie G. Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia. Haematologica. 2014;99:e199\u2013200.","journal-title":"Haematologica"},{"key":"1951_CR30","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood.V84.6.2050.2050","volume":"84","author":"M Kohli-Kumar","year":"1994","unstructured":"Kohli-Kumar M, Morris C, DeLaat C, Sambrano J, Masterson M, Mueller R, Shahidi NT, Yanik G, Desantes K, Friedman DJ, et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood. 1994;84:2050\u20134.","journal-title":"Blood"},{"key":"1951_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1956.tb06875.x","volume":"45","author":"R Kostmann","year":"1956","unstructured":"Kostmann R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl. 1956;45:1\u201378.","journal-title":"Acta Paediatr Suppl"},{"key":"1951_CR32","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1182\/blood-2003-10-3518","volume":"103","author":"C Bellanne-Chantelot","year":"2004","unstructured":"Bellanne-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, Vaury C, Barkaoui M, Fenneteau O, Maier-Redelsperger M, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood. 2004;103:4119\u201325.","journal-title":"Blood"},{"key":"1951_CR33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3324\/haematol.2009.017665","volume":"95","author":"M Germeshausen","year":"2010","unstructured":"Germeshausen M, Zeidler C, Stuhrmann M, Lanciotti M, Ballmaier M, Welte K. Digenic mutations in severe congenital neutropenia. Haematologica. 2010;95:1207\u201310.","journal-title":"Haematologica"},{"key":"1951_CR34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng1170","volume":"34","author":"RE Person","year":"2003","unstructured":"Person RE, Li FQ, Duan Z, Benson KF, Wechsler J, Papadaki HA, Eliopoulos G, Kaufman C, Bertolone SJ, Nakamoto B, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003;34:308\u201312.","journal-title":"Nat Genet"},{"key":"1951_CR35","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/pbc.25528","volume":"62","author":"EJ Sayour","year":"2015","unstructured":"Sayour EJ, Carter C, Eldjerou L. A novel ELANE gene mutation in a patient with severe congenital neutropenia and intermittent thrombocytopenia. Pediatr Blood Cancer. 2015;62:1870\u20131.","journal-title":"Pediatr Blood Cancer"},{"key":"1951_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2015.1.1","volume":"2015","author":"IP Touw","year":"2015","unstructured":"Touw IP. Game of clones: the genomic evolution of severe congenital neutropenia. Hematology Am Soc Hematol Educ Program. 2015;2015:1\u20137.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1951_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","volume":"72","author":"DC Dale","year":"2003","unstructured":"Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol. 2003;72:82\u201393.","journal-title":"Am J Hematol"},{"key":"1951_CR38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJM198906153202402","volume":"320","author":"MA Bonilla","year":"1989","unstructured":"Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, Abboud M, Fumagalli L, Vincent M, Gabrilove JL, Welte K, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989;320:1574\u201380.","journal-title":"N Engl J Med"},{"key":"1951_CR39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.patbio.2014.05.008","volume":"62","author":"JH Dalle","year":"2014","unstructured":"Dalle JH, Donadieu J, Paillard C, Rialland F, Schneider P, Sicre De Fontbrune F, Hichri Y, Neven B, Yakoub-Agha I, Sfgm TC. [SFGM-TC recommendation on indications for allogeneic stem cell transplantation in children with congenital neutropenia]. Pathol Biol (Paris). 2014;62:209\u201311.","journal-title":"Pathol Biol (Paris)"},{"key":"1951_CR40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bmt.1704718","volume":"35","author":"C Ferry","year":"2005","unstructured":"Ferry C, Ouachee M, Leblanc T, Michel G, Notz-Carrere A, Tabrizi R, Flood T, Lutz P, Fischer A, Gluckman E, Donadieu J. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant. 2005;35:45\u201350.","journal-title":"Bone Marrow Transplant"},{"key":"1951_CR41","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2015-02-628859","volume":"126","author":"F Fioredda","year":"2015","unstructured":"Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, Aljurf M, Peters C, Calvillo M, Matthes-Martin S, et al. Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation. Blood. 2015;126:1885\u201392.","journal-title":"Blood"},{"key":"1951_CR42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1399-3046.2010.01319.x","volume":"14","author":"K Oshima","year":"2010","unstructured":"Oshima K, Hanada R, Kobayashi R, Kato K, Nagatoshi Y, Tabuchi K, Kato S. Hematopoietic Stem Cell Transplantation Committee of the Japanese Society of Pediatric H: hematopoietic stem cell transplantation in patients with severe congenital neutropenia: an analysis of 18 Japanese cases. Pediatr Transplant. 2010;14:657\u201363.","journal-title":"Pediatr Transplant"},{"key":"1951_CR43","first-page":"45","volume":"90","author":"J Donadieu","year":"2005","unstructured":"Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, Maier-Redelsperger M, Micheau M, Stephan JL, Phillipe N, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica. 2005;90:45\u201353.","journal-title":"Haematologica"},{"key":"1951_CR44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MPH.0000000000000487","volume":"38","author":"S Osone","year":"2016","unstructured":"Osone S, Imamura T, Fukushima-Nakase Y, Kitamura-Masaki A, Kanai S, Imai T, Imashuku S, Kuroda H. Case reports of severe congenital neutropenia treated with unrelated cord blood transplantation with reduced-intensity conditioning. J Pediatr Hematol Oncol. 2016;38:49\u201352.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1951_CR45","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V89.7.2578","volume":"89","author":"JE Anderson","year":"1997","unstructured":"Anderson JE, Gooley TA, Schoch G, Anasetti C, Bensinger WI, Clift RA, Hansen JA, Sanders JE, Storb R, Appelbaum FR. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy. Blood. 1997;89:2578\u201385.","journal-title":"Blood"},{"key":"1951_CR46","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.leu.2403431","volume":"18","author":"B Cassinat","year":"2004","unstructured":"Cassinat B, Bellanne-Chantelot C, Notz-Carrere A, Menot ML, Vaury C, Micheau M, Bader-Meunier B, Perel Y, Leblanc T, Donadieu J, Chomienne C. Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register. Leukemia. 2004;18:1553\u20135.","journal-title":"Leukemia"},{"key":"1951_CR47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood.V97.3.829","volume":"97","author":"M Germeshausen","year":"2001","unstructured":"Germeshausen M, Ballmaier M, Schulze H, Welte K, Flohr T, Beiske K, Storm-Mathisen I, Abrahamsen TG. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood. 2001;97:829\u201330.","journal-title":"Blood"},{"key":"1951_CR48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjh.12638","volume":"164","author":"Y Ebihara","year":"2014","unstructured":"Ebihara Y, Ishikawa K, Mochizuki S, Tanaka R, Manabe A, Iseki T, Maekawa T, Tsuji K. Allogeneic stem cell transplantation for patients with acute myeloid leukaemia developing from severe congenital neutropenia. Br J Haematol. 2014;164:459\u201361.","journal-title":"Br J Haematol"},{"key":"1951_CR49","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1365-2141.2002.03585.x","volume":"118","author":"Y Dror","year":"2002","unstructured":"Dror Y, Freedman MH. Shwachman-diamond syndrome. Br J Haematol. 2002;118:701\u201313.","journal-title":"Br J Haematol"},{"key":"1951_CR50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng1062","volume":"33","author":"GR Boocock","year":"2003","unstructured":"Boocock GR, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR, Rommens JM. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003;33:97\u2013101.","journal-title":"Nat Genet"},{"key":"1951_CR51","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2011.057489","volume":"97","author":"J Donadieu","year":"2012","unstructured":"Donadieu J, Fenneteau O, Beaupain B, Beaufils S, Bellanger F, Mahlaoui N, Lambilliotte A, Aladjidi N, Bertrand Y, Mialou V, et al. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica. 2012;97:1312\u20139.","journal-title":"Haematologica"},{"key":"1951_CR52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2011.06349.x","volume":"1242","author":"Y Dror","year":"2011","unstructured":"Dror Y, Donadieu J, Koglmeier J, Dodge J, Toiviainen-Salo S, Makitie O, Kerr E, Zeidler C, Shimamura A, Shah N, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann NY Acad Sci. 2011;1242:40\u201355.","journal-title":"Ann NY Acad Sci"},{"key":"1951_CR53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bmt.1705553","volume":"39","author":"M Sauer","year":"2007","unstructured":"Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Welte K, Lohse P, Sykora KW. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. Bone Marrow Transplant. 2007;39:143\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"1951_CR54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bjh.12787","volume":"165","author":"F Fagioli","year":"2014","unstructured":"Fagioli F, Quarello P, Zecca M, Lanino E, Corti P. avre F, Ripaldi M, Ramenghi U, Locatelli F, Prete A: haematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Italian association of paediatric haematology and oncology registry. Br J Haematol. 2014;165:673\u201381.","journal-title":"Br J Haematol"},{"key":"1951_CR55","first-page":"3715","volume":"116","author":"A Vlachos","year":"2010","unstructured":"Vlachos A, Muir E. How I treat Diamond-Blackfan anemia. Blood. 2010;116:3715\u201323.","journal-title":"How I treat Diamond-Blackfan anemia. Blood"},{"key":"1951_CR56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0031-1291377","volume":"37","author":"M Ballmaier","year":"2011","unstructured":"Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost. 2011;37:673\u201381.","journal-title":"Semin Thromb Hemost"},{"key":"1951_CR57","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.bbmt.2013.12.099","volume":"20","author":"JH Dalle","year":"2014","unstructured":"Dalle JH, Fahd M. Allogeneic stem cell transplantation in amegacaryocytosis: results of a retrospective study in EBMT centers. Biol Blood Marrow Transplant. 2014;20:S81\u20132.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1951_CR58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/petr.12577","volume":"19","author":"KM Mahadeo","year":"2015","unstructured":"Mahadeo KM, Tewari P, Parikh SH, Driscoll TA, Page K, Martin PL, Kurtzberg J, Prasad VK. Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation. Pediatr Transplant. 2015;19:753\u20137.","journal-title":"Pediatr Transplant"},{"key":"1951_CR59","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3046.2007.00721.x","volume":"11","author":"J Fuente de la","year":"2007","unstructured":"de la Fuente J, Dokal I. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr Transplant. 2007;11:584\u201394.","journal-title":"Pediatr Transplant"},{"key":"1951_CR60","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.bmt.1703931","volume":"31","author":"Y Dror","year":"2003","unstructured":"Dror Y, Freedman MH, Leaker M, Verbeek J, Armstrong CA, Saunders FE, Doyle JJ. Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita. Bone Marrow Transplant. 2003;31:847\u201350.","journal-title":"Bone Marrow Transplant"},{"key":"1951_CR61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.1998.00949.x","volume":"103","author":"V Rocha","year":"1998","unstructured":"Rocha V, Devergie A, Socie G, Ribaud P, Esperou H, Parquet N, Gluckman E. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol. 1998;103:243\u20138.","journal-title":"Br J Haematol"},{"key":"1951_CR62","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","volume":"19","author":"SM Gadalla","year":"2013","unstructured":"Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, et al. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant. 2013;19:1238\u201343.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1951_CR63","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3324\/haematol.2010.027839","volume":"96","author":"R Bizzetto","year":"2011","unstructured":"Bizzetto R, Bonfim C, Rocha V, Socie G, Locatelli F, Chan K, Ramirez O, Stein J, Nabhan S, Miranda E, et al. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica. 2011;96:134\u201341.","journal-title":"Haematologica"},{"key":"1951_CR64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","volume":"46","author":"AC Dietz","year":"2011","unstructured":"Dietz AC, Orchard PJ, Baker KS, Giller RH, Savage SA, Alter BP, Tolar J. Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. Bone Marrow Transplant. 2011;46:98\u2013104.","journal-title":"Bone Marrow Transplant"},{"key":"1951_CR65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3046.2010.01431.x","volume":"15","author":"N Nishio","year":"2011","unstructured":"Nishio N, Takahashi Y, Ohashi H, Doisaki S, Muramatsu H, Hama A, Shimada A, Yagasaki H, Kojima S. Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita. Pediatr Transplant. 2011;15:161\u20136.","journal-title":"Pediatr Transplant"},{"key":"1951_CR66","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000318721","volume":"124","author":"LG Vuong","year":"2010","unstructured":"Vuong LG, Hemmati PG, Neuburger S, Terwey TH, Vulliamy T, Dokal I, le Coutre P, Dorken B, Arnold R. Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita. Acta Haematol. 2010;124:200\u20133.","journal-title":"Acta Haematol"},{"key":"1951_CR67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","volume":"23","author":"SA Savage","year":"2009","unstructured":"Savage SA, Alter BP. Dyskeratosis congenita. Hematol Oncol Clin North Am. 2009;23:215\u201331.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1951_CR68","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1705839","volume":"40","author":"K Amarasinghe","year":"2007","unstructured":"Amarasinghe K, Dalley C, Dokal I, Laurie A, Gupta V, Marsh J. Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan. Bone Marrow Transplant. 2007;40:913\u20134.","journal-title":"Bone Marrow Transplant"},{"key":"1951_CR69","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bmt.1705171","volume":"36","author":"P Brazzola","year":"2005","unstructured":"Brazzola P, Duval M, Fournet JC, Gauvin F, Dalle JH, Champagne J, Champagne MA. Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen. Bone Marrow Transplant. 2005;36:1103\u20135 (author reply 1105).","journal-title":"Bone Marrow Transplant"},{"key":"1951_CR70","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2013.35","volume":"48","author":"M Ayas","year":"2013","unstructured":"Ayas M, Nassar A, Hamidieh AA, Kharfan-Dabaja M, Othman TB, Elhaddad A, Seraihy A, Hussain F, Alimoghaddam K, Ladeb S, et al. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. Bone Marrow Transplant. 2013;48:1168\u201372.","journal-title":"Bone Marrow Transplant"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-1951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-016-1951-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-1951-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T09:37:37Z","timestamp":1718357857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-016-1951-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s12185-016-1951-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}